Gene | Name/protein | Function | Risk/other disease | References |
Chromatin remodelling, transcription, translation | ||||
MECP2 | Methyl-CpG-binding protein 2 | Histone methylation, chromatin remodelling, transcriptional repression | ↑ ASD + Rett syndrome | 11 |
FMR1 | Fragile X mental retardation 1/FMRP | mRNA binding, maturation, transport to cytosol | ↑ ASD + fragile X syndrome | 12 |
EIF4E | Eukaryotic translation initiation 4E | CYFIP1-EIF4E-FMR1 complex mediates translational repression | ↑ ASD + fragile X syndrome | 35 40 |
CYFIP1 | Cytoplasmic FMRP-interacting protein 1 | CYFIP1-EIF4E-FMR1 complex mediates translational repression | ↑ ASD +SCHZ + fragile X syndrome | 35 40 |
MEF2C | Myocyte-specific enhancer factor 2C | MEF2 transcription factor family, regulates synapse number | ↑ ASD in de novo mutations | 77 |
HDAC4 | Histone deacetylase 4 | Histone deacetylation, chromatin remodelling, transcriptional repression | ASD | 78 |
CHD8 | Chromodomain-helicase-DNA-binding protein 8 | Transcriptional regulator, represses CTNNB1, regulates brain growth, interacts with COMPASS | ↑ ASD in de novo mutations + macrocephaly | 57 58 |
CHD7 | Chromodomain-helicase-DNA-binding protein 7 | Transcriptional regulator, positive regulator of rRNA biogenesis | ASD + CHARGE syndrome | 79 |
KMT2A | Lysine (K)-specific methyltransferase 2A | Subunit of Histone methyltransferase COMPASS complex | ASD in de novo mutations | 57 58 |
KMT2C | Lysine (K)-specific methyltransferase 2C | Subunit of Histone methyltransferase COMPASS complex | ASD in de novo mutations | 57 58 |
SMARCC1,2 | SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin C1 and 2 | Chromatin remodelling, regulates neurogenesis | ASD variants | 57 |
SMARCA2 | SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin A2 | Chromatin remodelling, regulates neurogenesis | SCHZ variants | 80 |
TBR1 | T-box brain 1 | Transcription factor, regulates neurogenesis | ↑ ASD in de novo mutations | 81 |
FOXP1 | Forkhead Box P1 | Transcription factor, mTOR signalingfoxp1 | ASD in de novo mutations | 73 |
CTNNB1 | Catenin β1 | Transcription factor, activates WNT and regulates brain growth | ASD | 57 58 |
EIF4E | Eukaryotic translation initiation factor 4E | cap-dependent translation downstream of mTOR. Regulates other ASD genes with synaptic roles | ASD variants | 82 |
TAF1L | TAF1 RNA pol II, TATA box binding protein (TBP)-associated factor | RNA pol II-mediated transcription | ASD in de novo mutations | 73 |
TAF13 | Transcription initiation factor TFIID subunit 13 | RNA pol II-mediated transcription | SCHZ de novo mutations | 40 |
SETD1A | SET domain containing 1A | Subunit of histone methyltransferase COMPASS complex | ↑ SCHZ, several mutations | 55 83 |
RBBP5 | Retinoblastoma-binding protein 5 | Subunit of Histone methyltransferase COMPASS complex | SCHZ variants | 84 |
C7orf60 | Probable methyltransferase BTM2 homologue | Probable S-adenosyl-L-methionine-dependent methyltransferase | SCHZ de novo mutations | 40 |
TRRAP | Transformation/transcription domain-associated protein | Component of the NuA4 histone acetyltransferase complex | SCHZ variants | 85 |
UBR5 | E3 ubiquitin-protein ligase | Promotes accumulation of 'Lys-63'-linked histone H2A and H2AX at DNA damage sites | SCHZ variants | 83 |
KDM2B | Lysine (K)-specific demethylase 2B | Demethylates 'Lys-4' and 'Lys-36' of histone H3 | SCHZ variants | 83 |
KDM5C | Lysine (K)-specific demethylase 5C | demethylates 'Lys-4' of histone H3 | SCHZ variants | 83 |
Signalling | ||||
NF-1 | Neurofibromin-1 | mTOR signalling, regulation of cell size | ↑ ASD + neurofibromatosis | 86 |
PTEN | Phosphatase and tensin homologue | mTOR signalling, regulation of cell size | ↑ ASD + PTEN macrocephaly | 87 |
SYNGAP1 | RAS GTPase-activating protein 1 | mTOR signalling, regulation of cell size | ASD de novo mutations | 35 40 |
TSC2 | Tuberous sclerosis 2 | mTOR signalling, regulation of cell size | ↑ ASD + tuberous sclerosis | 88 |
DYRK1A | Dual-specificity tyrosine phosphorylation regulated kinase 1A | Phosphorylation of actin complexes at synapse | ASD de novo mutations | 89 |
ASD,autism spectrum disorder; SCHZ, schizophrenia; SWI/SNF, switching/sucrose non-fermenting; FMRP, Fragile X mental retardation protein; mTOR, mammalian target of rapamycin.